Articles with public access mandates - Zoe SessionsLearn more
Not available anywhere: 1
Natural products as potential agents against SARS-CoV and SARSCoV-2
JP Raimundo e Silva, CAH Acevedo, TA de Souza, RPB de Menezes, ...
Current Medicinal Chemistry 28 (27), 5498-5526, 2021
Mandates: US National Institutes of Health
Available somewhere: 5
Recent progress on cheminformatics approaches to epigenetic drug discovery
Z Sessions, N Sánchez-Cruz, FD Prieto-Martínez, VM Alves, HP Santos Jr, ...
Drug Discovery Today 25 (12), 2268-2276, 2020
Mandates: US National Institutes of Health
Conserved coronavirus proteins as targets of broad-spectrum antivirals
CC Melo-Filho, T Bobrowski, HJ Martin, Z Sessions, KI Popov, ...
Antiviral Research 204, 105360, 2022
Mandates: US National Institutes of Health
Allosteric binders of ACE2 are promising anti-SARS-CoV-2 agents
JE Hochuli, S Jain, C Melo-Filho, ZL Sessions, T Bobrowski, J Choe, ...
ACS Pharmacology & Translational Science 5 (7), 468-478, 2022
Mandates: US National Institutes of Health
Praemonitus praemunitus: can we forecast and prepare for future viral disease outbreaks?
Z Sessions, T Bobrowski, HJ Martin, JMT Beasley, A Kothari, T Phares, ...
FEMS Microbiology Reviews 47 (5), fuad048, 2023
Mandates: US National Institutes of Health
Novel Pharmacokinetics Profiler (PhaKinPro): Model Development, Validation, and Implementation as a Web-Tool for Triaging Compounds with Undesired PK Profiles
M Rath, J Wellnitz, HJ Martin, C Melo-Filho, J Hochuli, GM da Silva, ...
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program